Interestingly, the ST6GAL1 did not significantly differ between COVID-19 severity suggesting that a portion of the increased sialylation on IgM is due to the α-2,3 sialyltransferase ST3GAL4 (Supplemental Table 7). The gene discussed is ST6GAL1; the disease is COVID-19.